Is Cormedix Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: CRMD) stock is to Buy CRMD stock.
Out of 3 analysts, 0 (0%) are recommending CRMD as a Strong Buy, 3 (100%) are recommending CRMD as a Buy, 0 (0%) are recommending CRMD as a Hold, 0 (0%) are recommending CRMD as a Sell, and 0 (0%) are recommending CRMD as a Strong Sell.
According to 3 Wall Street analysts that have issued a 1 year CRMD price target, the average CRMD price target is $12.33, with the highest CRMD stock price forecast at $19.00 and the lowest CRMD stock price forecast at $6.00.
On average, Wall Street analysts predict that Cormedix's share price could reach $12.33 by Aug 10, 2024. The average Cormedix stock price prediction forecasts a potential upside of 236.05% from the current CRMD share price of $3.67.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.